Fabrazyme is the proven therapy with
over 17 years of real-world experience
and has been chosen for over
5000 patients worldwide, regardless of
genotype or disease severity.1
Indication and Usage
Fabrazyme is indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease.
ERT=Enzyme replacement therapy
Fabry disease is a progressive, often life-threatening disease. Undiagnosed and unmanaged, Fabry disease can reduce life expectancy
by approximately 15 years in women and 20 years in men.2-4 Learn more about managing Fabry disease.